and for new visitors to this forum- there is so much more to the Phosphagenics story than just Transdermal Insulin,
POH has a very full, advanced and lucrative pipeline that has several projects close to commercialisation
R&D Pipeline
The pharmaceutical division is currently engaged in R&D of the following:
Drug Delivery - Transdermal
Morphine Pain Management
Insulin Diabetes
Oxycodone Pain Management
Drug Delivery - Localised
Lidocaine Pain Management
Diclofenac Pain Management
Drug Delivery - Dermal
Retinoic Acid Acne
Drug Enhancement - Oral
Phospha E Metabolic Syndrome
There is also substantial research in Drug enhancement for Atherosclerosis (APA01) and Anti- Cancer GTP-0805
GTP-0805 is an anti-cancer agent with anti-proliferative properties and is thought to exert its activity through modulation of pathways involved in the pathogenesis of cancer.
Then we have Nutraceuticals, This is the use of vitamins and nutritious products to improve human health. The POH nutraceutical business is developing active ingredients for the following market segments:
Dietary Supplements - e.g. vitamin capsules & tablets;
Personal Care - e.g. skin care products; and
Functional Foods and Beverages - e.g. nutritionally enhanced foods.
POH already receives income from global sales of Vital-ET
We are now currently awaiting news on a deal wih Nestle( the worlds largest food co) to use our Phospha E and a new range of Nestle produced functional foods.
So many projects - so many deals to be done
- Forums
- ASX - By Stock
- theres no business like poh business
and for new visitors to this forum- there is so much more to the...
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.635K | 1.045M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 93538418 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 60456317 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 93288418 | 0.002 |
19 | 68595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 60329190 | 20 |
0.004 | 17087707 | 16 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online